chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1216 the patient was asked if he was feeling okay. Reported that he was dizzy. Did not eat today. RN removed his mask and began to take vitals. Mom reports that last time he had blood drawn he got dizzy too. First set of vitals: 90/40, 100% spo2, 94 hr. Put patient in Trendelenburg 12:20 92/44, 95%, 75 hr. 12:25 98/60, 99%, 82 hr. 12:27 sat up pt states no dizziness. 102/50, 100%, 85 hr. 12:30 pt helped to standing position states he is feeling good. 102/64, 100%, 95 hr. 1242 patient re-evaluated before discharge, patient states he is feeling back to normal. 102/58, 99%, 95 hr sitting in chair. 12:45 left with mom.
I do not have this vaccine information specifically as it was not given by my office. It was given in the patient's workplace office
Cellulitis formed in the area of her arm where she received the vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient received BNT162b2 (BNT162B2), on 31May2022 as dose 4 (booster), single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history included: "Interchange of vaccine" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Moderna (DOSE 1), for COVID-19 immunization; Moderna (DOSE 2), for COVID-19 immunization; Moderna (DOSE 3), for COVID-19 immunization. The following information was reported: ADMINISTRATION SITE CELLULITIS (non-serious), outcome "unknown", described as "Cellulitis formed in the area of her arm where she received the vaccine".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recvd vax;lab eval revealed a neg varicella antibody;test repeated 7oct95 & still neg;
severe reaction of tinnitus in the ears; demeanor is changing; stressed out; This is a spontaneous report from a contactable consumer (patient mother). A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number and expiration date was not provided) via an unspecified route on an unspecified date (reported as two Saturdays ago) as a single dose for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, patient had severe reaction of tinnitus in the ears, demeanor was changing stated her life was going to crap in conjunction with the side effect and life issues. Patient life was better until she got the Pfizer shot, it is ruining and destroying patients life. Reporter stated that patient cannot live like this and looks beaten down and was stressed out. Reporter inquired that was there an avenue or category to put people into that, this vaccine was changing their life. Patient will not get the second dose. Outcome for the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I95.9 HYPOTENSION 4/23/2023 DM 2 W RENAL MANIFESTATION R09.02 HYPOXEMIA 4/14/2023 DM 2 W RENAL MANIFESTATION
The pt received his primary SPV in the left upper arm on 5/22/12. He was in his normal state of good health at the time. About 2 days later he noticed that he was fatigued. On day 3 he noted generalize muscle aches and axillary and cervical lymphadenopathy. On day 7 he felt feverish and chilled-he did not seek medical attention nor did he miss any work days. Additionally, on 5/29/12 (day 7) he noted a 2 minute episode of left sided dull, non-radiating, chest pain (2/10) while at rest. The pt denied N, V, SOB or diaphoresis. He thought that might have "heartburn" as he had eaten fried food for dinner (the pt denies prior hx of "heartburn"). The symptoms resolved without treatment. The pt experienced a second episode of substernal chest pain (4/10) while resting on 6/2/12. The pain lasted about 10 minutes and radiated from the sternum to the anterior chest. It resolved without treatment. He denied any other symptoms (N, V, diaphoresis, SOB). On 6/11/12 around 10 am while at work he noted 10/10 severe substernal chest "pressure" which improved leaning forward and worsened with leaning back. He was diaphoretic and nauseated (he denied V, SOB, or palpitations). The pt stated that the pain radiated to both arms intermittently. The pt reported to the ER. He had a normal PE (no murmur, no chest tenderness). He was given MOTRIN at 1100 with improvement of his chest pain (5/10) after about 90 minutes. The EKG showed NSR with early repolarization. CSR results are below. He was diagnosed with pericarditis and he was started on NAPROSYN 500 mg bid. He was seen in Cardiology Clinic on 6/18/12 where he reported that he continues to experience substernal chest pressure which lasts about 2 minutes and occurs about 2 minutes and occurs about 3 time per day (unrelated to activity). He had an EKG which showed NSR and a normal ECHO. He was diagnosed with atypical chest pain; instructed to continue NAPROSYN bid for 2 more weeks; stress echo will be considered if pain continues or worsens.
Redness - 6 cm of raised induration with 3 cm of small blistering lesions in center.
Since 26 November she has complained of recurrent episodes of localized itching and rashes described as raised, red, itchy whelts which can occur anywhere on her body from the waist up and typically occur at sites of pressure or where her skin is scraped or scratched. Lesions last less than 24 hours, spare her palms and soles, and resolve without post-inflammatory changes. She denies generalized cutaneous, laryngeal, pulmonary, GI/GU, neurologic, and cardiovascular symptoms with these episodes. Episodes not associated with exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, infections, or insect bites/stings. She received her Moderna COVID-19 vaccine booster dose on 19 November, seven days prior to onset of symptoms. She has used oral antihistamines with control of symptoms. She denies constitutional symptoms. score today is 25 (2, 4, 4, 3, 3, 3, 3, 3).
Debilitating headache, nausea, neck pain/stiffness, fatigue.
This case was reported by a consumer via call center representative and described the occurrence of pain in a several other adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced pain. On an unknown date, the outcome of the pain was unknown. It was unknown if the reporter considered the pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group was not reported but was selected as adult as per vaccine indication. The reporter had a lot of other people report, they also had soreness. No new adverse event report filed for these a lot of other people and soreness. The reporter also experienced soreness (refer case US2019GSK050679) and stated she expected it as it was a common side effect. The reporter requested to stop further follow up.
Itchy, rash (small raised bumps, red) and hives where scratched on neck and chest. (Note: also extreme soreness in arm where vaccine administered).
1/27/20 am - large local swelling to vaccine site with hives. Hives spread to the rest of the body. 0 respiratory distress. Allergic urticaria. Zyrtec 5 mg bid Imp. by ENT - avoid T/Dap due to suspected allergic reaction
Narrative:  A 72yo male with PMH of Depressive Disorder, Tobacco Use Disorder, Barret's Esophagus, Esophageal Reflux with Esophagitis, Thyroid nodule, Lumbar Spondylosis, HTN, A-fib, Adenocarcinoma of Duodenum Per Nurse's documentation, he received Pfizer Covid-19 vaccine per policy and protocol without complication First dose on February 15, 2021 and second dose on March 8 2021 No ADE was reported The patient had stage 4 Gastric Cancer The system showed he passed away on 4/4/21
Pain at injection site; Achy; This is a spontaneous report received from a Pfizer Sponsored Program. A contactable consumer (patient spouse) reported that an unspecified aged male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection) dose 1 via an unspecified route of administration on an unspecified date as 1st dose, single dose and dose 2 via an unspecified route of administration on an unspecified date as 2nd dose, single dose for COVID-19 immunization. Medical history included COVID virus and was hospitalized, previous to getting the vaccine. The patient's concomitant medications were not reported. On an unspecified date it was reported as patient's spouse stated that her husband had both of his vaccines, confirmed as the Pfizer COVID vaccine later in the report. He had pain at the injection site and was achy. She stated that her husband had the COVID virus also and was hospitalized, previous to getting the vaccine. She stated that his events were minor and declines to complete a report for him. The outcome of the events was unknown.  Information about lot/batch number has been requested.
Severe response to second vaccination including passing out in my home hallway, and violent vomiting and fever for 12 hours after that. Starting the following month (June 2021) I began experiencing severe nausea and mental health challenges before ovulation and menstruation. Symptoms continued to get worse every month with increased vomiting, diarrhea, and panic episodes. I just had an ovary removed 3 weeks ago in hopes of finding a cause/solution. I have experienced rapid heart rate, swollen lymph nodes in my underarms, and extreme fatigue. One of my doctors diagnosed me with ?Major Neurocognative disorder due to covid vaccination?
Patient received the adult dose of Pfizer (12+) but was just short of his 12th birthday (3 days). No adverse reaction occurred.
This case was reported by a physician via sales rep and described the occurrence of local reaction in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced local reaction. On an unknown date, the outcome of the local reaction was unknown. It was unknown if the reporter considered the local reaction to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not applicable for this report. The age group was not provided, but was selected adult as per the vaccine indication. The physician stated that he saw larger local reactions in patients who received SHINGRIX vaccines versus other vaccines, but he felt that was due to the SHINGRIX adjuvant. The physician did not agree for follow up.
8 days after 2nd vaccine I got swollen lymph node under left armpit with pain to Side of breast and upper front left shoulder along with tingly numbing sensation down left arm.  Now I have been having chest pain, with numbing zapping feeling in my chest and now both arms. Tendon and join point as well.
Red face, fever, chills, rapid heartbeat, joint pain and stiffness, hives on left arm, swollen lymph nodes under left arm, muscle pain over entire body for 2 days.
Mild discomfort at site of injection.  It was more acute 9 to 20 hours after the vaccination, but began to subside thereafter. Tiredness.  Overnight following the injection and up until midday the day after I was noticeably fatigued
Arm bright red from elbow to arm pit. Severe burning. Swelling from elbow to shoulder and into armpit. Lasted 6 weeks before swelling and burning went away.
Patient came to counter complaining of feeling in throat. Clinic doctoer checked bp and stated no signs of allergic reaction. Recheck in 30 minutes and patient went home,
PT c/o soreness, swelling, discoloration. Initially  @ 24 hr had fever when Sx started - Rt arm 2 cm diameter, red, gl taken, Resolving after 2nd day.  Still Symptomatic States getting better
My symptoms that began in January for COVID-19 were fever, body aches, coughing but no difficulty breathing. I tested positive on January 26, 2023. I took TYLENOL or ibuprofen for pain. I was back at work on the 30th so I know I was feeling better by then. The next health event after that happened on March 3, 2023. I had a fever the first day but mostly it was congestion, runny nose, cough and extreme amounts of mucus. I was coughing or blowing nose with mucus every five minutes. I contact my doctor on the 6th and was prescribed azithromycin. I still have not completely recovered from this.
Ringing in ears, jaw tightness, lightheadedness, chest tightness 20 after Engerix-B #1
30 minutes after Varivax injection, this child developed urticaria, edema lips and eyelids, and skin itching. Improved after Epinephrine given.
This spontaneous report as received from a registered nurse refers to a 6 year old patient of unknown gender. On 14-NOV-2014 the patient was inadvertently received a dose of ZOSTAVAX (lot# reported as J009992, dose, dose# and route unspecified) in error. The patient was scheduled to receive (Merck) VARIVAX. No dose of (Merck) VARIVAX was administered. No adverse effects reported. The outcome of the event was not reported. Additional information has been requested.
I'm having extreme menstrual side effects.  After my second shot in April, by May my period was a little bit heavier and ran longer than normal, but it didn't worry me. I usually only menstruate 4 days and this ended up being 5-6 days and heavier.  However, by June my period was about 36 days late from the last cycle and no I'm not pregnant and I wasn't pregnant, but at first I attributed it to stress, however,  when it finally did show up on (June 22) I bled for 14 days straight and it was heavier than normal.  By July 5, I thought that was the end of my period, but two days later I started bleeding again and this time not only was it was heavier (gushing) but I was passing abnormally large blood clots. I've never experienced anything like this before, and if you look online there are a bunch of women going through the exact same symptoms as me after getting the vaccine. I actually have another close friend who has had issues with her period right after getting the vaccine.   So, I went to see my primary doctor on July 23rd and she put me on birth control to help with the bleeding, to get my hormones and cycle back on track. As of now, I'm still bleeding, but it's lighter. I do still pass clots every now and then, but it's not as bad as it was when I wasn't on birth control meds.  I just want to report this to you (the CDC) because this needs to be researched. Other women shouldn't have to be worried or surprised by these side effects. As well, we women need to know what are the lasting side effects of the vaccines? Is this excessive bleeding and clotting a short term thing? Is this going to make us infertile? Will our menstrual cycles regular in a few months? We just need answers. It's really scary when it's happening to you and no one (the CDC, health professionals, the media) aren't talking about it openly.
typical sore arm; 17yr old got the 1st shot of Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17yr old got the 1st shot of Vaccine) and ARTHRALGIA (typical sore arm) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 026C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17yr old got the 1st shot of Vaccine). On an unknown date, the patient experienced ARTHRALGIA (typical sore arm). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17yr old got the 1st shot of Vaccine) and ARTHRALGIA (typical sore arm) outcome was unknown.            No treatment or concomitant products reported Action taken with mRNA-1273 in response to the drug was not applicable. Patient was experienced no adverse effects from either dose other than the typical sore arm.   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: follow up received and  Added contact information for the patient's Medical Doctor and her Registered Nurse to our records On 21-Jun-2021: Follow up received Provides significant information patient demographics ( patient Initial, Race, Ethnic group, Height, Weight) added Second dose information, batch number for first dose were added. event typical sore arm was added. On 18-Jul-2021: NNI FU - No new information was provided.
chills; vomiting; This is a spontaneous report from a contactable consumer (patient's mother). A 16-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, (Batch/Lot number was not reported) via an unspecified route of administration on 08Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The caller (mother of the patient) calling on the behalf of her daughter and reported chills and vomiting. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Within 3 hours of receiving the vaccine I began to feel severely light headed; Fatigued; Short of breath; Pressure in my chest; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 18Sep2021 (Lot number: EW0191) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose no: 1), for COVID-19 immunization. The following information was reported: DIZZINESS (non-serious) with onset Sep2021, outcome "recovered" (2021), described as "Within 3 hours of receiving the vaccine I began to feel severely light headed"; FATIGUE (non-serious) with onset Sep2021, outcome "recovered" (2021), described as "Fatigued"; DYSPNOEA (non-serious) with onset Sep2021, outcome "recovered" (2021), described as "Short of breath"; CHEST DISCOMFORT (non-serious) with onset Sep2021, outcome "recovered" (2021), described as "Pressure in my chest". The events "within 3 hours of receiving the vaccine i began to feel severely light headed", "fatigued", "short of breath" and "pressure in my chest" were evaluated at the emergency room visit.  Additional information: Within 3 hours of receiving the vaccine patient began to feel severely light headed, fatigued, short of breath and pressure in chest. Symptoms did not resolve after 48 hours, at which time contacted primary care provider's office and was directed to immediately go to the ER for an evaluation. On 20Sep2021, After 3 hours in the ER, and many tests later, patient was diagnosed with an adverse event to a vaccine. Symptoms that warranted an ER visit slowly resolved over the next week.   Follow-up attempts are completed. No further information is expected.
Pt experienced and area of swelling, redness, firm and warm to touch. Pt was treated with Benadryl.
606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  On 17-Nov-2021 the vaccine placed in refrigerator. There was no temperature excursion and the patient did not experience any adverse event.
Consistant break out of puss filled pimple type rash that itches unbearably for over a year since original outbreak immediately after vaccination of November 7th, 2014 administered by Dr at Clinic - Referred to another clinic for triamcinolone treatment with limited results - Currently suffering with condition a year later.
EXCRUCIATING HEADACHE; FEVER; This spontaneous report received from a parent concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 18-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 18-JUL-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103. On 27-JUL-2021, the subject experienced excruciating headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 19-JUL-2021, and had not recovered from excruciating headache. This report was non-serious.
Patient is a91y.o. year old male presented to ER 10/11 PM after falling off toilet. Patient was on the ground for approximately 1.5 hours. Patient admits to increased weakness and fatigue. He reports a chronic cough which is unchanged. Patient denied fever. He admits to exposure to COVID + family members at a family function 1 week ago.  Patient has received Pfizer vaccine x 2,  2/2021. Patient tested + for COVID 10/11. Patient was not requiring supplemental O2. I personally discussed with Dr. who was the patient advocate. The patient and Dr. agreed to Monoclonal antibody which was administered 10/12  Patient is resting comfortably on room air at the time of my exam today. 94% room air. He was noted to have a transient desaturation to 85 % at 4AM which has resolved. Discussed with Dr. Will continue to monitor pulse ox . If persistent desaturation is noted will consider additional treatment. At this time will monitor off decadron/remdesivir and antibiotics.   Minimal procalcitonin elevation noted however not significant in patient with acute/chronic kidney disease. family reports recent urinary incontinence. U/A not suggestive of UTI. Suspect recent changes may be related to COVID, will monitor.
pain in the injection site.; redness, swelling and pain in the injection site.; swelling and pain in the injection site.; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain, injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site pain, injection site erythema and injection site swelling were unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema and injection site swelling to be related to Shingrix.  Additional details were reported as follows: The age group was not reported but was selected as adult as per vaccine indication. Pharmacist reported that every once in a while she has a patient that received a dose of Shingrix and develops redness, swelling and pain in the injection site.  The reporter did not consent to follow-up.